Ibezapolstat

DB16189InvestigationalSmall molecule

Ibezapolstat is under investigation in clinical trial NCT04247542 (ACX-362E Ibezapolstat for Oral Treatment of Clostridioides Difficile Infection).

Chemical structure of Ibezapolstat
Formula / weight
C18H20Cl2N6O2 · 423.3 g/mol (avg)
Code names
ACX-362E

Resolves to

Compound
UNII5K543KNC5PCAS1275582-97-2
Structure
InChIKeyDEGSGBKTODESHH-UHFFFAOYSA-NSMILESClC1=C(Cl)C=C(CNC2=NC(=O)C3=C(N2)N=CN3CCN2CCOCC2)C=C1

What you can answer from here — as of April 23, 2025

2Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Ibezapolstat, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In